Dr Reddy's Laboratories (DRL) on Wednesday said profit advanced 25% (YoY) at Rs 262.74 crore for the first quarter of this fiscal, almost in line with analysts' estimates, as key drugs aided sales in North America. In an interview with CNBC-TV18, GV Prasad, vice-chairman & CEO of DRL spoke about the company
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
